Drug Pipeline

Gallium-68 labelled (68Ga-) FAP-2286 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
3
Recruiting
4
Top Sponsors
Active Studies by Phase
Phase 2
1
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07523607 FAP PET/CT for Staging Patients With Breast Cancer Breast Cancer Detection Not Yet Recruiting
Phase 1/2
NCT04939610 A Study of 177Lu-FAP-2286 in Advanced Solid Tumors Solid Tumor Recruiting
Phase 1
NCT07144085 Application of ⁶⁸Ga-FXX489 (NNS309) PET/CT Imaging in Diagnosis of Tumor Diseases. Tumor Recruiting
NCT04621435 Imaging of Solid Tumors Using FAP-2286 Solid Tumors, Adult Recruiting
Sponsors Running Gallium-68 labelled (68Ga-) FAP-2286 Trials
Thomas Hope (1) Novartis Pharmaceuticals (1) Yi Tian (1) Odense University Hospital (1)
Disease Areas
Breast Cancer (1)
Get alerts when Gallium-68 labelled (68Ga-) FAP-2286 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free